Saturday 17 October 2026 Export HALO’s income statement to Excel — free account

Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 37.6% from fiscal 2024. In the quarter to June 2026, revenue grew 47.7%, EPS grew 44.1%, free cash flow grew 141.2% and total debt rose 42.2%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

121.84 0.33 +0.27%

Follow HALO

Alert me

Market cap: $13.8B
P/E: 34.6×
Fwd P/E: 10.6×
Dividend yield: —
F-score: 5/9
Altman Z: 3.46
Beneish M: −2.59
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Cash and Short Term Investments Full definition →	+8 more quarters Free account	701.96	142.82	318.62	231.00
Receivables Full definition →		346.04	441.27	457.99	455.83
Inventory Full definition →		185.80	176.48	155.47	137.14
Total current assets Full definition →		1,328.75	825.21	1,003.04	933.02
Property, Plant, Equpment (Net) Full definition →		71.42	82.14	82.23	84.27
Goodwill and Intangible Assets (Total) Full definition →		765.37	1,561.83	1,534.28	1,504.18
Long-term assets (Other) Full definition →		55.70	56.15	53.18	55.94
Total non-current assets Full definition →		892.48	1,700.12	1,669.68	1,644.38
Total Assets Full definition →		2,221.23	2,525.32	2,672.72	2,577.41
Accounts Payable Full definition →		15.36	20.90	14.10	23.61
Accrued Expenses Full definition →		111.18	156.19	140.37	111.86
Current Part of Debt Full definition →		710.69	—	208.74	208.97
Total current liabilities Full definition →		837.23	177.09	363.21	344.44
Long Term Debt (Total) Full definition →		800.07	2,142.63	1,935.90	1,937.68
Long Term Tax Liability (Deferred) Full definition →		8.22	42.92	47.53	49.06
Non-current Liabilities (Other) Full definition →		71.80	113.86	106.45	102.68
Total non-current liabilities Full definition →		880.09	2,299.42	2,089.87	2,089.43
Total liabilities Full definition →		1,717.32	2,476.51	2,453.08	2,433.87
Additional Paid In Capital Full definition →		23.91	12.00	27.39	—
Common Stock (Net) Full definition →		0.12	0.12	0.12	0.11
Retained Earnings Full definition →		502.15	54.79	204.84	151.26
Common Equity (Total) Full definition →		503.92	48.81	219.64	143.54
Shareholders Equity (Total) Full definition →		503.92	48.81	219.64	143.54
Shareholders Equity and Liabilities (Total) Full definition →		2,221.23	2,525.32	2,672.72	2,577.41
Shares (Common) Full definition →		117.52	117.78	118.52	114.04
Shareholders Equity (Tangible) Full definition →		(261.45)	(1,513.01)	(1,314.64)	(1,360.63)
Net Debt Full definition →		808.79	1,999.81	1,826.02	1,915.65
Total Debt Full definition →		1,510.76	2,142.63	2,144.64	2,146.65

Fold the line items

In millions of $ except per-share values · columns are period end dates

Stockrow Weekly